News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,369 Results
Type
Article (42372)
Company Profile (202)
Press Release (705777)
Multimedia
Podcasts (122)
Webinars (16)
Section
Business (210304)
Career Advice (1943)
Deals (35291)
Drug Delivery (147)
Drug Development (80117)
Employer Resources (159)
FDA (16285)
Job Trends (15450)
News (349709)
Policy (33030)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Standard (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (2793)
Accelerated approval (56)
ADA (49)
Adcomms (33)
Allergies (207)
Alliances (46422)
ALS (233)
Alzheimer's disease (1919)
Antibody-drug conjugate (ADC) (553)
Approvals (16740)
Artificial intelligence (794)
ASCO (332)
Autoimmune disease (359)
Automation (63)
Bankruptcy (333)
Best Places to Work (12326)
BIOSECURE Act (23)
Biosimilars (246)
Biotechnology (139)
Bladder cancer (210)
Brain cancer (81)
Breast cancer (832)
Cancer (6580)
Cardiovascular disease (554)
Career advice (1597)
Career pathing (29)
CAR-T (375)
CDC (52)
Celiac Disease (2)
Cell therapy (1039)
Cervical cancer (56)
Clinical research (70402)
Collaboration (2371)
Commercialization (1)
Company closure (7)
Compensation (1540)
Complete response letters (99)
COVID-19 (2565)
CRISPR (122)
C-suite (1303)
Cystic fibrosis (164)
Data (8801)
Decentralized trials (3)
Denatured (26)
Depression (193)
Dermatology (96)
Diabetes (695)
Diagnostics (7495)
Digital health (69)
Diversity (7)
Diversity, equity & inclusion (40)
Drug discovery (388)
Drug pricing (201)
Drug shortages (33)
Duchenne muscular dystrophy (310)
Earnings (101585)
Editorial (71)
Employer branding (21)
Employer resources (126)
Events (133094)
Executive appointments (1200)
FDA (20394)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1940)
Gene editing (263)
Generative AI (67)
Gene therapy (811)
GLP-1 (1199)
Government (5125)
Grass and pollen (8)
Guidances (421)
Healthcare (20985)
Hematology (197)
HIV (94)
Huntington's disease (65)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (115)
Immunology and inflammation (349)
Immuno-oncology (111)
Indications (214)
Infectious disease (2963)
Inflammatory bowel disease (242)
Inflation Reduction Act (14)
Influenza (151)
Intellectual property (323)
Interviews (330)
IPO (17254)
IRA (52)
Job creations (3437)
Job search strategy (1382)
JPM (66)
Kidney cancer (22)
Labor market (117)
Layoffs (637)
Leadership (25)
Legal (7750)
Liver cancer (109)
Longevity (34)
Lung cancer (868)
Lymphoma (480)
Machine learning (64)
Management (44)
Manufacturing (1185)
Marketing (1)
MASH (223)
Medical affairs (1)
Medical device (15024)
Medtech (15194)
Mergers & acquisitions (19432)
Metabolic disorders (1750)
mRNA (239)
Multiple sclerosis (207)
NASH (21)
Neurodegenerative disease (496)
Neuropsychiatric disorders (125)
Neuroscience (3653)
Neurotech (1)
NextGen: Class of 2026 (7107)
Non-profit (5083)
Now hiring (63)
Obesity (815)
Opinion (278)
Ovarian cancer (244)
Pain (282)
Pancreatic cancer (360)
Parkinson's disease (419)
Partnered (28)
Patents (652)
Patient recruitment (773)
Peanut (71)
People (59350)
Pharmaceutical (40)
Pharmacy benefit managers (34)
Phase 1 (22008)
Phase 2 (31176)
Phase 3 (23348)
Pipeline (9944)
Policy (310)
Postmarket research (2202)
Preclinical (9274)
Press Release (71)
Prostate cancer (352)
Psychedelics (64)
Radiopharmaceuticals (367)
Rare diseases (1236)
Real estate (5796)
Recruiting (61)
Regulatory (26076)
Reports (66)
Research institute (2553)
Resumes & cover letters (342)
Rett syndrome (43)
RNA editing (24)
RSV (99)
Schizophrenia (194)
Series A (334)
Series B (240)
Service/supplier (9)
Sickle cell disease (126)
Special edition (32)
Spinal muscular atrophy (179)
Sponsored (38)
Startups (3407)
State (2)
Stomach cancer (19)
Supply chain (139)
Tariffs (72)
The Weekly (94)
Vaccines (1158)
Venture capital (124)
Weight loss (547)
Women's health (134)
Worklife (16)
Date
Today (113)
Last 7 days (466)
Last 30 days (2680)
Last 365 days (32383)
2026 (16573)
2025 (32440)
2024 (37301)
2023 (42378)
2022 (53016)
2021 (57338)
2020 (56692)
2019 (50580)
2018 (37405)
2017 (33675)
2016 (33119)
2015 (38524)
2014 (31629)
2013 (26798)
2012 (28035)
2011 (28758)
2010 (25654)
Location
Africa (757)
Alabama (101)
Alaska (7)
Arizona (334)
Arkansas (16)
Asia (44383)
Australia (7277)
California (14310)
Canada (4008)
China (1574)
Colorado (617)
Connecticut (635)
Delaware (443)
Europe (100077)
Florida (2156)
Georgia (466)
Hawaii (3)
Idaho (65)
Illinois (1199)
India (101)
Indiana (662)
Iowa (24)
Japan (605)
Kansas (135)
Kentucky (55)
Louisiana (61)
Maine (89)
Maryland (1734)
Massachusetts (10474)
Michigan (409)
Minnesota (794)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (30)
Nevada (155)
New Hampshire (91)
New Jersey (3820)
New Mexico (34)
New York (3779)
North Carolina (1896)
North Dakota (11)
Northern California (7213)
Ohio (451)
Oklahoma (27)
Oregon (46)
Pennsylvania (2822)
Puerto Rico (33)
Rhode Island (51)
South America (1143)
South Carolina (89)
South Dakota (2)
Southern California (5687)
Tennessee (230)
Texas (2311)
United States (51122)
Utah (430)
Vermont (2)
Virginia (363)
Washington D.C. (80)
Washington State (1164)
West Virginia (4)
Wisconsin (151)
Wyoming (2)
748,369 Results for "20".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
May 24, 2026
·
4 min read
Press Releases
Cytokinetics to Hold Annual Meeting of Stockholders - May 20, 2026
May 21, 2026
·
3 min read
Press Releases
RadioMedix to Present at SNMMI 2026 and Mark 20 Years of Radiopharmaceutical Innovation
May 28, 2026
·
4 min read
Press Releases
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
April 7, 2026
·
5 min read
Press Releases
Akeso’s Next-Generation HER3 ADC AK138D1 Combined with Ivonescimab: First Patient Enrolled in Phase Ib/II Breast Cancer Study, Advancing the IO2.0 + ADC2.0 Strategy
June 15, 2026
·
6 min read
Press Releases
Emergent BioSolutions to Participate in Upcoming Investor Conferences - May 20, 2026
May 20, 2026
·
1 min read
Press Releases
Syndax Announces Participation in Upcoming Investor Conferences - May 20, 2026
May 20, 2026
·
1 min read
Press Releases
Thermo Fisher Scientific Announces Quarterly Dividend - May 20, 2026
May 21, 2026
·
1 min read
Press Releases
C4 Therapeutics to Participate in Upcoming Conferences - May 20, 2026
May 20, 2026
·
1 min read
Press Releases
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
May 20, 2026
·
3 min read
1 of 74,837
Next
